The Changing Face of Lung Cancer: Why Non-Smokers and Women Face Rising Risks
Lung cancer rates are shifting, with more women and non-smokers receiving diagnoses. Explore the environmental, genetic, and screening factors involved.
POLICY WIRE — Miami, USA — The traditional perception of a lung cancer patient as an older, long-term smoker is increasingly outdated. Over the past 15 years, medical professionals have observed a significant shift in demographics, with rising diagnosis rates among women, younger individuals, and those who have never smoked.
Lung cancer now stands as the primary cause of cancer-related mortality for women, claiming more lives annually than breast, ovarian, and colorectal cancers combined. Data from the American Lung Association indicates that while male lung cancer rates have dropped by 43% over the last 44 years, rates among women have surged by 79%. Notably, for the first time, more young women are being diagnosed with the disease than men.
Public awareness regarding these trends intensified following the Oct. 13, 2026, announcement of Pope Leo XIV’s lung cancer diagnosis, despite his history as a non-smoker. Experts emphasize that environmental factors and genetics play critical roles in these cases, making early detection vital for patients regardless of their smoking status.
Thoracic oncologist Estelamari Rodriguez, Associate Director of Community Outreach in Thoracic Oncology at the University of Miami, notes that the unexpected nature of the diagnosis in non-smokers often leads to clinical delays. Because these patients fall outside current screening guidelines, tumors are frequently discovered only by chance rather than through routine testing.
Historical patterns help explain the rise in female cases, as women began smoking later than men, shifting the peak of smoking-related diagnoses. Furthermore, the introduction of filtered cigarettes may have contributed to higher rates of adenocarcinoma, as filters can redirect smoke into the outer regions of the lungs. Research also suggests women may be more susceptible to the carcinogenic effects of tobacco and secondhand smoke.
Beyond tobacco, risk factors include exposure to radon, asbestos, air pollution, and workplace chemicals like nickel, silica, and arsenic. Emerging research is also investigating the potential risks associated with marijuana and e-cigarette use, alongside the role of hereditary genetic predispositions.
In 2021, the United States Preventive Services Task Force expanded screening recommendations to include adults aged 50 to 80 with a 20-pack-year smoking history. While these guidelines are expected to increase eligible women by 40%, current participation remains low, with less than 6% of eligible smokers undergoing recommended low-dose CT scans.
Advancements in targeted therapies and immunotherapies have improved prognoses, particularly for women with specific molecular changes. However, symptoms such as persistent coughing, fatigue, and chest pain are often overlooked or misattributed to other conditions, especially in younger patients.
Reporting by Policy-Wire (PW)
